Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa
Blood · 23.03.2023 · 141 (12) · 1402-1410
DOI: 10.1182/blood.2022017051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, erschienen am 23.03.2023. Verfasst von Peter Olupot-Olupot und 12 weiteren Autor:innen. Beteiligte Einrichtung: Mbale Clinical Research Institute, Mbale, Uganda. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Malaria. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, NHLBI NIH HHS, Medical Research Council.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Realizing Effectiveness Across Continents with Hydroxyurea (REACH, NCT01966731) provides hydroxyurea at maximum tolerated dose (MTD) for children with sickle cell anemia (SCA) in sub-Saharan Africa. Beyond reducing SCA-related clinical events, documented treatment benefits include ∼50% reduction in malaria incidence. To identify associations and propose mechanisms by which hydroxyurea could be associated with lower malaria rates, infections were recorded across all clinical sites (Angola, Democratic Republic of Congo, Kenya, and Uganda). Hazard ratios (HR) with 95% confidence intervals (CIs) for baseline demographics, and time-varying laboratory and clinical parameters were estimated in a modified Cox gap-time model for repeated events. Over 3387 patient-years of hydroxyurea treatment, 717 clinical malaria episodes occurred in 336 of 606 study participants; over half were confirmed by blood smear and/or rapid diagnostic testing with 97.8% Plasmodium falciparum. In univariate analysis limited to 4 confirmed infections per child, malaria risk was significantly associated with absolute neutrophil count (ANC), splenomegaly, hemoglobin, and achieving MTD; age, malaria season, MTD dose, fetal hemoglobin, α-thalassemia, and glucose-6-phosphate dehydrogenase deficiency had no effect. In multivariable regression of confirmed infections, ANC was significant (HR, 1.37 per doubled value; 95% CI, 1.10-1.70; P = .0052), and ANC values <3.0 × 109/L were associated with lower malaria incidence. Compared with nonpalpable spleen, 1- to 4-cm splenomegaly also was associated with higher malaria risk (HR, 2.01; 95% CI, 1.41-2.85; P = .0001). Hydroxyurea at MTD is associated with lower malaria incidence in SCA through incompletely defined mechanisms, but treatment-associated mild myelosuppression with ANC <3.0 × 109/L is salutary. Splenomegaly is an unexplained risk factor for malaria infections among children with SCA in Africa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Mbale Clinical Research Institute, Mbale, Uganda.
- Mbale Regional Referral and Teaching Hospital/Busitema University, Mbale, Uganda.
- Department of Medicine, University Health Network and Mt Sinai Hospital, Toronto, ON, Canada.
- University of Toronto, Toronto, ON, Canada.
- KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
- Institute of Global Health Innovation, Imperial College, London, United Kingdom.
ORCID-Profile: George Tomlinson, Thomas N Williams, Luke R Smart, Russell E Ware
Förderung
- Wellcome Trust
- NHLBI NIH HHS
- Medical Research Council
Zitieren
APA
Olupot-Olupot, P., Tomlinson, G., Williams, T. N., Tshilolo, L., Santos, B., Smart, L. R., McElhinney, K., Howard, T. A., Aygun, B., Stuber, S. E., Lane, A., Latham, T. S., & Ware, R. E. (2023). Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa. Blood, 141(12), 1402-1410. https://doi.org/10.1182/blood.2022017051
Vancouver
Olupot-Olupot P, Tomlinson G, Williams TN, Tshilolo L, Santos B, Smart LR, et al. Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa. Blood. 2023;141(12):1402-1410. doi:10.1182/blood.2022017051
BibTeX
@article{OlupotOlupot2023,
author = {Olupot-Olupot, Peter and Tomlinson, George and Williams, Thomas N and Tshilolo, Léon and Santos, Brígida and Smart, Luke R and McElhinney, Kathryn and Howard, Thad A and Aygun, Banu and Stuber, Susan E and Lane, Adam and Latham, Teresa S and Ware, Russell E},
title = {Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa},
journal = {Blood},
year = {2023},
volume = {141},
number = {12},
pages = {1402--1410},
doi = {10.1182/blood.2022017051}
}
EUVIMED